Skip to main content

Table 2 Chromogenic substrate test

From: Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs

Correlation at trough (24 h)

R-C

aFXa Rivaroxaban

0,6881

 

P = 0.0001

Correlation at peak (2 h)

 

aFXa Rivaroxaban

0,3908

 

P = 0.033

  1. Coefficient of correlations between R-C and rivaroxaban in plasma
  2. R-C Ratio patient plasma / normal plasma